[HTML][HTML] Circulating long non-coding RNAs act as biomarkers for predicting 131I uptake and mortality in papillary thyroid cancer patients with lung metastases

ZL Qiu, CT Shen, Z Sun, WJ Wei, XY Zhang… - Cellular Physiology and …, 2016 - karger.com
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer and accounts
… ) are RNA molecules that are longer than 200 nucleotides and not translated into proteins [7]. …

The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer

C Colombo, E Minna, C Gargiuli, M Muzza… - … & Clinical Cancer …, 2020 - Springer
… b Clinical and molecular features of the patients included in the 3 different RAI classes.
Note … of fusion genes in PTCs with initial RAI uptake, but without therapeutic efficacy (RAI+/D+), …

The Molecular Effect of Diagnostic Absorbed Doses from 131I on Papillary Thyroid Cancer Cells In Vitro

M Stasiołek, Z Adamczewski, PW Śliwka, B Puła… - Molecules, 2017 - mdpi.com
… radioiodine uptake—the phenomenon called “thyroid stunning”. … the metastasis of human
PTC [20] to characterize molecular … Unfortunately, we were not able to extensively investigate …

Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes

J Simões-Pereira, A Saramago, R Rodrigues, M Pojo… - Endocrine, 2024 - Springer
molecular markers that may help to predict RAI avidity and RAI therapy response of metastatic
lesions in a cohort of papillary thyroid cancer (PTC… significant did not evidence RAI uptake. …

[HTML][HTML] Molecular features of aggressive thyroid cancer

G Elia, A Patrizio, F Ragusa, SR Paparo… - Frontiers in …, 2022 - frontiersin.org
no kind of correlation between BRAF V600E and any of the PTC aggressiveness features
(… of the capacity to uptake RAI after a previous WBS showing avidly uptake RAI metastases; a …

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131i uptake in metastases

Z Meng, M Matsuse, V Saenko, S Yamashita… - IUBMB …, 2019 - Wiley Online Library
… in not only development of papillary thyroid carcinoma (PTC) but also determination of its
properties. The … in PTC has unveiled an uncharted territory of molecular diagnosis for predicting …

Analysis of factors influencing the clinical outcome after surgery and 131I therapy in patients with moderate-risk thyroid papillary carcinoma

Y Li, M Rao, C Zheng, J Huang, D Fang… - Frontiers in …, 2022 - frontiersin.org
… type of thyroid carcinoma is papillary thyroid carcinoma (PTC), … , the residual thyroid tissue
before 131 I treatment was not … I uptake rate, which is closely related to the residual thyroid

[HTML][HTML] Thyroid functional and molecular imaging

L Giovanella, AM Avram, PP Ovčariček, J Clerc - La Presse Médicale, 2022 - Elsevier
… and may not parallel the absolute radiotracer uptake. In other … uptake is found in thyroid
cancer compared to normal thyroid … included papillary thyroid carcinoma (PTC) which is cancer

Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond

P Santhanam, LB Solnes, SP Rowe - Medical Oncology, 2017 - Springer
… -stage PTCs since 1983 and that annual thyroid cancer … for the detection of thyroid cancer
that is not radioiodine avid … thyroid tumors have demonstrated radiotracer uptake in both …

[PDF][PDF] progression free survival related to F-FDG PET/CT 131 uptake and I uptake in lung metastases of differentiated thyroid cancer

X Zhu, S Wu, H Wang - Hell J Nucl Med, 2019 - nuclmed.gr
… scan uptake and also of iodine-131 ( I) in DTC patients with PM. Subjects and Methods: Out
Molecular targeting drugs may be indicated in these patients. A couple of studies evaluated …